Page 110 - 《中国药房》2022年10期
P. 110

the care of kidney transplant recipients[J]. Am J Trans-  [14]  YIN S F,SONG T R,JIANG Y M,et al. Tacrolimus
             plant,2009,9(Suppl 3):S1-S155.                      trough level at the first month may predict renal transplan-
        [ 3 ]  SINGH P,NG Y H,UNRUH M. Kidney transplantation    tation outcomes among living Chinese kidney transplant
             among the elderly:challenges and opportunities to im-  patients:a propensity score-matched analysis[J]. Ther
             prove outcomes[J]. Adv Chronic Kidney Dis,2016,23   Drug Monit,2019,41(3):308-316.
             (1):44-50.                                     [15]  JIANG Y M,SONG T R,QIU Y,et al. Outcomes of sin-
        [ 4 ]  RIELLA L V. Understanding the causes of mortality post-  gle kidney transplantation from pediatric donors:a sin-
             transplantation:there is more than meets the eye[J]. J Bras  gle-center experience[J]. Pediatr Transplant,2018,22(5):
             Nefrol,2018,40(2):102-104.                          e13196.
        [ 5 ]  HOSOHATA K,MATSUOKA E,INADA A,et al. Dif-    [16]  中华医学会器官移植学分会,中国医师协会器官移植医
             ferential profiles of adverse events associated with myco-  师分会.中国活体供肾移植临床指南:2016版[J].器官移
             phenolate mofetil between adult and pediatric renal trans-  植,2016,7(6):417-426.
             plant patients[J]. J Int Med Res,2018,46(11):4617-  [17]  YARLAGADDA S G,COCA S G,GARG A X,et al.
             4623.                                               Marked variation in the definition and diagnosis of de-
        [ 6 ]  CHHABRA D,SKARO A I,LEVENTHAL J R,et al.          layed graft function:a systematic review[J]. Nephrol Dial
             Long-term kidney allograft function and survival in pred-  Transplant,2008,23(9):2995-3003.
             nisone-free regimens:tacrolimus/mycophenolate mofetil
                                                            [18]  MALLON D H,SUMMERS D M,BRADLEY J A,et al.
             versus tacrolimus/sirolimus[J]. Clin J Am Soc Nephrol,
                                                                 Defining delayed graft function after renal transplantation:
             2012,7(3):504-512.
                                                                 simplest is best[J]. Transplantation,2013,96(10):885-
        [ 7 ]  中华医学会器官移植学分会.器官移植免疫抑制剂临床
                                                                 889.
             应用技术规范:2019 版[J].器官移植,2019,10(3):213-
                                                            [19]  中华医学会器官移植学分会.器官移植受者巨细胞病毒
             226.
                                                                 感染临床诊疗规范:2019 版[J].器官移植,2019,10(2):
        [ 8 ]  ZHANG J,LUO Y G,ZHU Z F,et al. Pharmacokinetic
                                                                 142-148.
             comparison of two mycophenolate mofetil formulations in
                                                            [20]  中华医学会器官移植学分会,中国医师协会器官移植医
             kidney transplant recipients[J]. Ther Drug Monit,2018,40
                                                                 师分会.中国实体器官移植受者侵袭性真菌病临床诊治
             (5):649-654.
                                                                 指南:2016 年版[J].中华器官移植杂志,2016,37(6):
        [ 9 ]  CAI W,CAI Q,XIONG N,et al. Limited sampling strate-
                                                                 300-305.
             gy for estimating mycophenolic acid exposure on day 7
                                                            [21]  中华人民共和国卫生部.血细胞分析参考区间:WS/T
             post-transplant for two mycophenolate mofetil formula-
                                                                 405-2012[S/OL].[2021-11-30]. http://www.nhc.gov.cn/wjw/
             tions derived from 20 Chinese renal transplant recipients
                                                                 s9492/201301/d893733b674945afa63bc33f3cc7e60d.shtml.
             [J]. Transplant Proc,2018,50(5):1298-1304.
                                                            [22]  KIM S J,SCHAUBEL D E,FENTON S S A,et al. Morta-
        [10]  石炳毅,于立新,陈立中,等.不同剂型吗替麦考酚酯用于
                                                                 lity after kidney transplantation:a comparison between
             同种肾移植的有效性和安全性比较[J].中华泌尿外科杂
                                                                 the United States and Canada[J]. Am J Transplant,2006,6
             志,2007,28(11):725-728.
                                                                (1):109-114.
        [11]  李玉凤,张胜利,姚家琳,等.关于国产吗替麦考酚酯分散
                                                            [23]  WADHWA R K,NAZEER A,RAI A A,et al. Role of
             片与进口胶囊预防肾移植术后急性排斥反应的比较[J].
                                                                 endoscopic findings and biopsies in renal transplant reci-
             临床荟萃,2010,25(13):1134-1137.
        [12]  张彦选,曲青山,苗书斋,等.吗替麦考酚酯分散片在活体                         pients with gastrointestinal complications:a tertiary care
             亲属肾移植后早期应用:与吗替麦考酚酯胶囊的对                              experience[J]. Exp Clin Transplant,2018,16(5):522-
             比[J].中国组织工程研究与临床康复,2010,14(31):                     527.
             5709-5712.                                     [24]  孙雯,郭宏波,解泽林,等.肾移植患者术后腹泻的相关因
        [13]  WANG X D,LIU J P,FAN Y,et al. Individualized precon-  素分析[J].北京大学学报(医学版),2013,45(5):779-
             ditioning for ABO-incompatible living-donor kidney trans-  781.
             plantation:an initial report of 48 cases from China[J]. Ann  (收稿日期:2021-11-05  修回日期:2022-04-28)
             Transplant,2020,25:e920224.                                                         (编辑:胡晓霖)








        ·1252 ·  China Pharmacy 2022 Vol. 33 No. 10                                 中国药房    2022年第33卷第10期
   105   106   107   108   109   110   111   112   113   114   115